The study will evaluate the treatment of hepatitis C genotype 1, 3 and 4 in people with impaired kidney function. The treatment duration is either 12 or 24 weeks.
Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency
To view the entire clinical trial information, click here
Share This Page